Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza
admitted to the intensive care unit (ICU). Classification of patients with influenza-associated …

Background The effect of corticosteroids on clinical outcomes in patients with influenza
pneumonia remains controversial. We aimed to further evaluate the influence of …

The COVID-19 outbreak has led to 80,409 diagnosed cases and 3,012 deaths in mainland
China based on the data released on March 4, 2020. Approximately 3.2% of patients with …

These clinical practice guidelines are an update of the guidelines published by the
Infectious Diseases Society of America (IDSA) in 2009, prior to the 2009 H1N1 influenza …

Rationale: Corticosteroid therapy is commonly used among critically ill patients with Middle
East Respiratory Syndrome (MERS), but its impact on outcomes is uncertain. Analyses of …

Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …

Since the 2019 novel coronavirus disease (COVID-19) outbreak originated from Wuhan,
Hubei Province, China, at the end of 2019, it has become a clinical threat to the general …

Background Specific treatments for influenza are limited to neuraminidase inhibitors and
adamantanes. Corticosteroids show evidence of benefit in sepsis and related conditions …

Annual seasonal influenza epidemics of variable severity result in significant morbidity and
mortality in the United States (US) and worldwide. In temperate climate countries, including …

Background Corticosteroids are commonly used as adjuvant therapy for acute respiratory
distress syndrome by many clinicians because of their perceived anti-inflammatory effects …